# Esomeprazole

## Emazole inj 40mg

| TAH Drug Code      | [IEMA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IEMA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Eosinophilic esophagitis; Gastroesophageal reflux disease, erosive or nonerosive; NSAID-induced gastric ulcers, prevention/treatment; Peptic ulcer disease, treatment of complicated ulcers; Stress ulcer prophylaxis in critically ill patients.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Dosing             | Adults For patients who cannot tolerate oral medication, an injection of 20–40 mg once daily can be administered. For patients with gastroesophageal reflux disease (GERD), a dose of 40 mg once daily should be used. For symptom management of reflux disease, 20 mg once daily is recommended. For the treatment of NSAID-associated gastric ulcers, the typical dose is 20 mg once daily. After therapeutic endoscopic intervention for acute bleeding gastric or duodenal ulcers, an 80 mg dose should be administered via rapid intravenous infusion over 30 minutes, followed by a continuous intravenous infusion at a rate of 8 mg/hour for 3 days (72 hours). --- Pediatrics Treatment of Erosive Reflux Esophagitis: - Ages 1–11 years: - Weight ?10 to <20 kg: 10 mg once daily - Weight ?20 kg: 10 mg or 20 mg once daily - Ages 12–18 years: 40 mg once daily Gastroesophageal Reflux Symptoms: - Ages 1–11 years: 10 mg once daily - Ages 12–18 years: 20 mg once daily                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Hypersensitivity (eg, anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis, urticaria) to esomeprazole, other substituted benzimidazole proton pump inhibitors, or any component of the formulation. Due to potentially significant reductions in nelfinavir exposure, avoid concurrent use of nelfinavir.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | >10%: Nervous system: Headache (IV: 11%; oral: children, adolescents, adults: 2% to 8%) 1% to 10%: Dermatologic: Pruritus (IV: 1%; oral: <1%) Endocrine & metabolic: Altered thyroid hormone levels (increased thyroxine: ?1%), decreased serum potassium (?1%), decreased serum sodium (?1%), decreased thyroid hormones (thyroxine: ?1%), increased serum potassium (?1%), increased serum sodium (?1%), increased thyroid stimulating hormone level (?1%), increased uric acid (?1%) Gastrointestinal: Abdominal pain (IV: 6%; oral: infants, children, adolescents, adults: 1% to 4%), acid regurgitation (infants: 1%), constipation (IV: 3%; oral: ?1%), diarrhea (IV: 4%; oral: children, adolescents, adults: 2% to 4%), flatulence (IV: 10%; oral: ?1%), increased gastrin (?1%), nausea (IV: 6%; oral: adolescents, adults: 2%), vomiting (infants: ?5%; adults: <1%), xerostomia (IV: 4%; oral: ?1%) Hematologic & oncologic: Increased hemoglobin (?1%), quantitative disorders of platelets (?1%) Hepatic: Increased serum alanine aminotransferase (infants, adults: ?1%), increased serum alkaline phosphatase (?1%), increased serum aspartate aminotransferase (?1%) Local: Injection-site reaction (IV: 2% to 4%) Nervous system: Dizziness (IV: ?3%; oral: <1%), drowsiness (children: 2%; adults: <1%), irritability (infants: ?5%), vertigo (IV: ?3%; oral: <1%) Renal: Increased serum creatinine (?1%) Respiratory: Cough (IV: 1%; oral: <1%), tachypnea (infants: 1%) Miscellaneous: Fever (IV: 4%; oral: <1%) <1%: Cardiovascular: Chest pain, edema, flushing, hypertension, lower extremity edema, peripheral edema, substernal pain, tachycardia Dermatologic: Acne vulgaris, dermatitis, diaphoresis, erythematous rash, maculopapular rash, skin rash, urticaria Endocrine & metabolic: Albuminuria, goiter, hot flash, hyperuricemia, hyponatremia, increased thirst, menstrual disease, vitamin B12 deficiency, weight gain, weight loss Gastrointestinal: Ageusia, anorexia, aphthous stomatitis, change in bowel habits, dysgeusia, dysphagia, enlargement of abdomen, eructation, exacerbation of constipation, gastroenteritis, gastrointestinal hemorrhage, hernia of abdominal cavity, hiccups, increased appetite, melena, mouth disease, pruritus ani, rectal disease, tongue disease Genitourinary: Cystitis, dysmenorrhea, dysuria, erectile dysfunction, genitourinary fungal infection, glycosuria, hematuria, polyuria, urinary frequency, urine abnormality, vaginitis Hematologic & oncologic: Anemia, cervical lymphadenopathy, gastrointestinal dysplasia, hypochromic anemia, leukocytosis, leukopenia, thrombocytopenia Hepatic: Hyperbilirubinemia Hypersensitivity: Angioedema, facial edema, hypersensitivity reaction, tongue edema Infection: Candidiasis (including esophageal candidiasis [Ma 2020], gastrointestinal candidiasis, genital candidiasis, and urogenital candidiasis) Nervous system: Altered sense of smell, apathy, asthenia, confusion, exacerbation of depression, fatigue, fibromyalgia syndrome, hypertonia, hypoesthesia, insomnia, malaise, migraine (including exacerbation of migraine headache), nervousness, pain, paresthesia, rigors, sleep disorder, tremor Neuromuscular & skeletal: Arthralgia, arthropathy, back pain, exacerbation of arthritis, muscle cramps, polymyalgia rheumatica Ophthalmic: Conjunctivitis, visual disturbance, visual field defect Otic: Otalgia, otitis media, tinnitus Respiratory: Dyspnea, epistaxis, exacerbation of asthma, flu-like symptoms, laryngeal edema, pharyngeal disease, pharyngitis, rhinitis, sinusitis. |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| More Info          | [UpToDate](https://www.uptodate.com/contents/esomeprazole-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

## Nexium 40mg

| TAH Drug Code      | [ONEX](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ONEX)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Gastroesophageal reflux disease. Treatment of erosive gastroesophageal reflux disease. Symptomatic treatment of gastroesophageal reflux disease. In combination with appropriate antimicrobial therapy to eradicate Helicobacter pylori and treat duodenal ulcers caused by Helicobacter pylori infection. For patients requiring continuous use of nonsteroidal anti-inflammatory drugs (NSAIDs). Treatment of NSAID-related gastric ulcers. Prevention of recurrent bleeding from peptic ulcers. Treatment of Zollinger-Ellison syndrome (ZES).                                                                                                                                                                                                                   |
| Dosing             | Erosive esophagitis - Gastroesophageal reflux disease treatment, 20 to 40 mg ORALLY once daily for 4 to 8 weeks; an additional 4 to 8 weeks may be considered if healing is not complete maintenance, 20 mg ORALLY once daily Gastroesophageal reflux disease - Heartburn 20 mg orally once daily for 4 weeks; an additional 4 weeks may be considered if symptoms do not completely resolve Helicobacter pylori gastrointestinal tract infection - Ulcer of duodenum Triple therapy, 40 mg orally once daily in combination with amoxicillin 1000 mg twice daily plus clarithromycin 500 mg twice daily for 10 days Gastric ulcer; Prophylaxis - NSAID-associated gastropathy; Prophylaxis 20 mg once daily 4-8 weeks Zollinger-Ellison syndrome 40 mg twice daily |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Patients with a known allergy to esomeprazole, benzimidazole derivatives, or any other components of the formulation. Esomeprazole should not be used in combination with nelfinavir.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Adverse Effects    | Headache, abdominal pain, diarrhea, flatulence, nausea, vomiting, constipation. Rarely, dermatitis, pruritus, urticaria, dizziness, dry mouth. Dermatologic: Injection site reaction (1.7%) Gastrointestinal: Abdominal pain (5.8%%), Constipation (2.5%), Diarrhea (3.9%), Flatulence (10.3%), Indigestion (6.4%), Nausea (6.4%), Xerostomia (3.9%) Neurologic: Dizziness (2.5%), Headache (10.9%)                                                                                                                                                                                                                                                                                                                                                                 |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| More Info          | [UpToDate](https://www.uptodate.com/contents/esomeprazole-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

